Skip to main content

Table 2 Drug Treatment (according to ATC-code)

From: Influence of patient symptoms and physical findings on general practitioners' treatment of respiratory tract infections: a direct observation study

Main groups Patients (%)
Cough and cold preparations (R05) 208 (76.2)
   Expectorants, excl. combinations with cough suppressants (R05C) 163 (59.7)
   Other cold combination preparations (R05X) 57 (20.9)
   Cough suppressants, excl. combinations with expectorants (R05D) 41 (15.0)
   Cough suppressants and expectorants, combinations (R05F) 14 (5.1)
Antibacterials for systemic use (J01) 134 (49.1)
   Macrolides and lincosamides (J01F) 52 (19.0)
   Beta-lactam antibacterials, penicillins (J01C) 27 (9.9)
   Cough suppressants and expectorants, combinations with antibacterials(*) (R05G) 25 (9.2)
   Other Beta-lactam antibacterials (J01D) 19 (7.0)
   Tetracyclines (J01A) 7 (2.9)
   Quinolone antibacterials (J01M) 4 (1.5)
Nasal preparations (R01) 43 (15.8)
Anti-Asthmatics (R03) 21 (7.7)
Throat preparations (R02) 10 (3.7)
Other (Breast unctions (R04), Echinacea-preparations (L03), otologicals (S02)) 18 (6.6)
  1. ((*)mostly tetracyclines, ATC = Anatomic, Therapeutic, Chemical Classification)